Posted on 29 Nov 2022 — The copyright holder is the author/funder. All rights reserved. No reuse without permission. — https://doi.org/10.22541/au.166971977.73825050/v1 — This a preprint and has not been peer reviewed. Data may be preliminary.
Ischemic stroke at first presentation of Takayasu arteritis in a young
African male from Kenya, East Africa: Case report and brief
literature review.
Christopher Owino1 , Betty Sirera2 , Felix Tarus2 , Beryl Ganda2 , Chrispine Oduor1 , and
Abraham Siika1
1
2
Moi University School of Medicine
Moi Teaching and Referral Hospital
November 29, 2022
Abstract
We present a case of a young, previously asymptomatic East-African black male presenting with large territory ischemic infarct
at first diagnosis of Takayasu arteritis (TA). To our knowledge, this is the first published report of a male patient in East Africa
with a stroke at the first presentation of TA.
Ischemic stroke at first presentation of Takayasu arteritis in a young African male from Kenya,
East Africa: Case report and brief literature review.
Owino Christopher1 , Sirera Betty2 , Tarus Felix2 , Ganda Beryl2 , Oduor Chrispine1 , Siika
Abraham1
Author affiliations
1 - Moi University School of medicine department of internal medicine, Eldoret, Kenya.
2 - Moi Teaching and Referral Hospital Eldoret, Kenya.
Informed written consent was sought and obtained from patient’s sister and is available upon
request from the journal.
ABSTRACT
We present a case of a young, previously asymptomatic East-African black male presenting with large
territory ischemic infarct at first diagnosis of Takayasu arteritis (TA). To our knowledge, this is the first
published report of a male patient in East Africa with a stroke at the first presentation of TA.
KEY CLINICAL MESSAGE
This case highlights the need for thorough clinical exam to rule out Takayasu arteritis (TA) as a cause of
stroke in a young asymptomatic East-African male. Available clinical management guidelines should guide
management of TA patients.
INTRODUCTIONTakayasu arteritis, a large vessel vasculitis characterized by inflammation of the aorta
or its branches was first described by Japanese Ophthalmologist Mikito Takayasu in 1908.(1) Despite initial
case reports and series highlighting most cases in young females of Asian origin it has since been shown to
have a worldwide occurrence affecting those under the age of 40 years.(2) Clinical presentation in Takayasu
1
Posted on 29 Nov 2022 — The copyright holder is the author/funder. All rights reserved. No reuse without permission. — https://doi.org/10.22541/au.166971977.73825050/v1 — This a preprint and has not been peer reviewed. Data may be preliminary.
arteritis can be non-specific with protean symptoms that are potentially difficult to pick. Here, we present
a case of a young African male presenting with a catastrophic cerebrovascular event at first presentation.
We describe his pattern of vascular involvement compared to other published cases and his management in
a resource limited.
CASE REPORT
We present a case of a 25-year-old black African male who presented to our hospital with a 2-day history
of sudden onset right sided weakness and inability to talk. He denied any history of headache, fever, prior
trauma or chest pain. Additionally, he had no history of chronic illness, intravenous drug use, cigarette
smoking, alcohol use or any personal or family history of hypertension, diabetes or cardiovascular disease.
Our patient had been working as a commercial motorcycle rider. General exam revealed a young man who
was awake and responsive, not in any respiratory distress with no conjunctival pallor. He had a blood pressure
reading of 130/79 mmHg on his right arm and 80/47 mmHg on the left arm revealing an obvious discrepancy
between the two arms. Our patient had motor aphasia with right sided cranial nerve 7,9,10,11 and 12 palsy.
Motor power of 0/5 on the right upper and lower limb on all muscle groups was noted with normal power
on the left. Additionally, we noted hyperreflexia and increased tone on the right limbs with normal global
sensation. No cerebellar signs were present. On cardiovascular exam our patient had absent pulses on the
left arm, an audible carotid bruit on the left with normal heart sounds without any murmur. A distended
bladder with urine retention was present on abdominal exam. Further systemic exam was non-revealing.
Working with a diagnosis of a cerebrovascular accident likely due to a large vessel vasculitis, a CT scan of the
head was ordered and showed a left sided fronto-temporal hypodensity consistent with an ischemic infarct.
(See figure 1.) Carotid doppler ultrasound revealed bilateral carotid artery stenosis with 50% occlusion
on the right and complete occlusion on the left. Further, a CT angiogram showed left subclavian artery
occlusion and bilateral carotid artery stenosis with complete occlusion on the left. (See figure 2 and 3.) A
2D transthoracic echocardiogram and ECG were normal. His screen for syphilis with VDRL was negative.
A CSF GeneXpert and BioFire® meningo-encephalitis panel were negative. Of note, ESR and CRP were
high with values of 85mm/hr. and 30.4mg/L respectively. Additionally, lipid profile results returned normal
with a negative HIV test by ELISA and antinuclear antibody test. His full hemogram and kidney function
tests were normal with a hemoglobin level of 15.4 g/dl. Based on the above clinical findings and tests, a
diagnosis of Takayasu Arteritis was made. Management was initiated with aspirin 75mg and our patient
pulsed with high dose methyl prednisone at one gram once daily for 3 days. Thereafter a maintenance dose
of azathioprine 100mg twice daily, deflazacort 6mg twice daily and physiotherapy was initiated. At 3 months
post discharge, he is doing well and has a power of 3/5 on the right lower limb, is able to talk with a slurred
speech with no other organ involvement noted.
DISCUSSION
Takayasu arteritis, a chronic disorder characterized by inflammation of the aorta or its branches is also
referred to as pulseless disease.(1) It has been more commonly reported among young female patients of
Asian origin. However, a more diverse global occurrence has been described in recent decades mostly among
individuals under the age of 40 years.(2)
Clinical presentation is commonly non-specific underscoring the need for a high index of suspicion to clinch
the correct diagnosis. The highly variable symptoms include fever, malaise, headaches, limb claudication
and hypertension with a classical triphasic pattern of presentation characterized by an initial period of
constitutional symptoms such as fever and night sweats in phase I, followed by pain over arteries in phase II
and finally a fibrotic phase leading to ischemic symptoms due to critical stenosis of large arteries has been
described.(3) However, literature seems to suggest that this picture is hardly seen in routine clinical practice
or in recent studies reports.(3,4). Due to extensive vascular involvement, Takayasu arteritis patients can
also present with 20mmHg systolic blood pressure measurement discrepancy between arms with impalpable
pulses on affected limb.(1) Thus, a through history and clinical exam remain a crucial tool in teasing out
Takayasu arteritis as a possible diagnosis among patients in the at-risk age group.
2
Posted on 29 Nov 2022 — The copyright holder is the author/funder. All rights reserved. No reuse without permission. — https://doi.org/10.22541/au.166971977.73825050/v1 — This a preprint and has not been peer reviewed. Data may be preliminary.
Based on the deep-seated nature of the vessel inflammation affecting large, high-pressure arteries such as the
thoracic and abdominal aorta or its branches, a tissue biopsy to confirm diagnosis is rarely feasible outside
autopsy. Therefore, clinical and radiological findings have been considered the standard for routine diagnosis.
Several diagnostic criteria have been described.(5,6). One of the most widely used is the American College
of Rheumatology (ACR) criteria which has 6 criteria. (See Table 1) Based on the ACR criteria, a diagnosis
can be made with a sensitivity of 90.5% and specificity of 97.8% when a patient meets at least 3 of the 6
criteria.(5) Our patient met four of the 6 criteria.
Table 1: The 1990 American College of Rheumatology Criteria for classification of Takayasu
arteritis. (5)
1.
2.
3.
4.
5.
6.
A diagnosis of Takayasu arteritis can be made with a sensitivity of 90.5% and specificity of 97.8% when a patient meets at l
Our case highlights an unfortunate occurrence where the patient had already developed a cerebrovascular
event at diagnosis, seen in up to 6-8% of patients at presentation and up to 20% in the course of the
illness.(7,8)
Also, important to note is the pattern of vascular involvement which can be identified both clinically but
more accurately radiologically (9). Takayasu arteritis can affect several large arteries. The pattern of vascular
involvement appears to vary with geographical region; patients in Japan and India have predominant aortic
arch and abdominal aorta lesions respectively on imaging. (10). Whereas patients with Takayasu arteritis
in Tunisia and Morocco in North Africa, tend to present with mostly aortic arch and/or subclavian artery
involvement as described by several authors. (11–13) Conversely, in South Africa, two case series including
the largest case series in Africa on Takayasu arteritis with two hundred and seventy two patients by Mwipatayi
et al describe more patients with hypertension as the presenting feature and predominant abdominal aorta
involvement compared to the aortic arch and its branches.(14,15)
The cases in literature describing patients from East Africa show a mixed pattern at initial presentation with
diffuse aortic and retinal involvement respectively in two cases in Tanzania. (16,17) Elsewhere in Uganda, a
case report describes autopsy findings of fibrosis in several branches of the arch of aorta. (18) In Kenya, two
cases have been reported, one presenting as chronic headache with carotid artery stenosis and thoracic aorta
involvement with another describing femoral involvement from biopsy of amputated limb in a set up with
limited angiography capabilities at the time. (19,20) Our patient had predominantly subclavian and carotid
artery involvement and no clear aortic localization which is similar to a case series description in Tunisia.
(13) Inflammatory markers such as erythrocyte sedimentation rate and C reactive protein are frequently
elevated as was the case in our patient but there are non-specific.
Generally, treatment is multidisciplinary with both medical and surgical interventions needed. Systemic
glucocorticoids form the backbone of medical treatment of Takayasu arteritis patients. Additionally, disease
modifying antirheumatic drugs (DMARDS) such as azathioprine and methotrexate are concomitantly used
to allow for tapering of steroids and minimize glucocorticoid associated side effects. Lastly, biologic agents
such as Tocilizumab and ant—Tumor Necrosis Factor inhibitors can be used. Surgery on the other hand is
usually indicated in critical vessel stenosis or to repair arterial aneurysms.
Two major rheumatology organizations namely EULAR and ACR have published guidelines on management
of Takayasu arteritis. However, the quality of evidence available to support these recommendations has
remained low. (21,22)
3
Posted on 29 Nov 2022 — The copyright holder is the author/funder. All rights reserved. No reuse without permission. — https://doi.org/10.22541/au.166971977.73825050/v1 — This a preprint and has not been peer reviewed. Data may be preliminary.
The European League Against Rheumatism (EULAR) 2018 guidelines offer several recommendations to guide
management of patients with Takayasu Arteritis. Acutely, EULAR supports initiation of glucocorticoids
plus disease modifying antirheumatic drug as initial treatment with tapering off of steroids as tolerated.
In refractory disease or major relapse, adjunctive therapy with Anti-IL6 agent tocilizumab and Anti- TNF
agents are recommended. More specifically, for minor relapses, a trial of re-institution of higher glucocorticoid
doses is advised before initiating Tocilizumab or anti-TNF agents. Additionally, for recurrent relapses
adjunctive therapy with biologic agents is advised. Antiplatelet agents are also not routinely recommended
and should only be considered on a case-by-case basis based on degree of stenosis and other risk factors.
Further, the EULAR guidelines recommend for vascular surgical interventions to be done electively during
stable remission since interventions during flares are associated with poor patency rates of repaired vessels.
However, whenever critical stenosis causing ischemia or dissecting aneurysms is present surgical intervention
should be pursued emergently. Finally, despite there being no research evidence to support follow up process,
initial close follow up of 1-3 monthly visits in the first year followed by 3-6 monthly visits afterwards is advised
due to high relapse rates. If relapse-free remission is achieved, then annual follow-ups can be scheduled
thereafter. During follow ups, clinical assessment including ESR and CRP measurements are advised with
imaging being ordered on a case-by-case basis. (21)
On the other hand, the American College of Rheumatology (ACR) guidelines are largely similar to the
EULAR guidelines except for a few subtle differences. Some of the most notable ones are recommendation
for use of ant-TNF inhibitors over Tocilizumab as initial addition in refractory disease and addition of aspirin
therapy in patients with active disease and critical cranial or vertebrobasilar involvement. Additionally,
despite recommending oral over intravenous glucocorticoids, the ACR guidelines give leeway for use of
intravenous pulse steroids in cases of organ or life threatening disease like in our patient’s case. (22)
Despite advances in diagnostic and treatment of Takayasu arteritis, the rate of complications prevails with
reported rates as high as 50%. Some of these complications include ischemic cerebrovascular incidences as
experienced by our patient, as well as aortic regurgitation and associated heart failure, end stage renal disease
in cases where renal vasculature has been involved. As expected, patients with more extensive disease at the
time of diagnosis have higher complication rates. (23,24) Similarly, patients with a more progressive course,
i.e., with few or no event free periods also experience higher rates of complications.(25)
Takayasu Arteritis has been described as a chronic condition with a relapsing pattern and this contributes
significantly to the morbidity of the patients.(26) Recent studies have found that the male sex, presence
of ongoing inflammation with elevated CRP levels and those carotidynia are more likely to experience
relapses.(27,28)
Although limited data is available, it should be noted that Takayasu Arteritis is associated with reduced
patient reported quality of life with patients with the disease also reported to have higher rates of clinical
depression and anxiety compared to the general population particularly during active disease.(29) It is
therefore important to ensure the evaluation of patients includes these aspects to ensure all concurrent
morbidities are appropriately evaluated and managed.
CONCLUSION
Although T.A remains an uncommon diagnosis, it is one to consider in patients presenting with physical
signs in keeping with its presentation including cerebrovascular vascular accidents even in African patients
where the disease is not highly prevalent. Early diagnosis and appropriate management will be essential in
reducing complication rates and improving outcomes.
CONFLICT OF INTEREST
The authors declare that they have no conflicts of interest.
AUTHOR CONTRIBUTIONS
All authors were involved in drafting the article or revising it, and all authors approved the final version to
4
be published.
Posted on 29 Nov 2022 — The copyright holder is the author/funder. All rights reserved. No reuse without permission. — https://doi.org/10.22541/au.166971977.73825050/v1 — This a preprint and has not been peer reviewed. Data may be preliminary.
References.
1. Sugiyama K, Ijiri S, Tagawa S, Shimizu K. Takayasu disease on the centenary of its discovery. Jpn J
Ophthalmol. 2009 Mar;53(2):81–91.
2. Watts RA, Hatemi G, Burns JC, Mohammad AJ. Global epidemiology of vasculitis. Nat Rev Rheumatol
[Internet]. 2022 Jan 1 [cited 2022 Sep 16];18(1):22. Available from: /pmc/articles/PMC8633913/
3. Quinn KA, Gribbons KB, Carette S, Cuthbertson D, Khalidi NA, Koening CL, et al. Patterns of clinical
presentation in Takayasu’s arteritis. Semin Arthritis Rheum. 2020 Aug 1;50(4):576–81.
4. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med [Internet]. 1994 Jun 1 [cited 2022 Sep 16];120(11):919–29. Available from:
https://pubmed.ncbi.nlm.nih.gov/7909656/
5. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College
of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum [Internet]. 1990
[cited 2022 Sep 16];33(8):1129–34. Available from: https://pubmed.ncbi.nlm.nih.gov/1975175/
6. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus
criteria* for the classification of childhood vasculitides. Ann Rheum Dis [Internet]. 2006 Jul [cited 2022 Sep
16];65(7):936. Available from: /pmc/articles/PMC1798210/
7. Sato EI, Hatta FS, Levy-Neto M, Fernandes S. Demographic, clinical, and angiographic data of patients
with Takayasu arteritis in Brazil. Int J Cardiol [Internet]. 1998 Oct 1 [cited 2022 Sep 16];66 Suppl 1(SUPPL.
1). Available from: https://pubmed.ncbi.nlm.nih.gov/9951804/
8. Arnaud L, Haroche J, Limal N, Toledano D, Gambotti L, Chalumeau NC, et al. Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, North African, and
black patients. Medicine (Baltimore) [Internet]. 2010 [cited 2022 Sep 16];89(1):1–17. Available from:
https://pubmed.ncbi.nlm.nih.gov/20075700/
9. Grayson PC, Tomasson G, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, et al. Association of
vascular physical examination findings and arteriographic lesions in large vessel vasculitis. J Rheumatol.
2012;39(2):303–9.
10. Moriwaki R, Noda M, Yajima M, Sharma BK, Numano F. Clinical manifestations of Takayasu arteritis
in India and Japan–new classification of angiographic findings. Angiology [Internet]. 1997 [cited 2022 Sep
16];48(5):369–79. Available from: https://pubmed.ncbi.nlm.nih.gov/9158381/
11. El Asri A, Tazi-Mezalek Z, Aouni M, Adnaoui M, Mohattane A, Bensaid Y, et al. [Takayasu’s disease in
Morocco. Report of 47 cases]. La Rev Med interne [Internet]. 2002 [cited 2022 Sep 16];23(1):9–20. Available
from: https://pubmed.ncbi.nlm.nih.gov/11859700/
12. Kechaou M, Frigui M, Hmida M Ben, Bahloul Z. Maladie de Takayasu au sud tunisien : étude de 29
cas. Presse Med. 2009 Oct 1;38(10):1410–4.
13. Ghannouchi Jaafoura N, Khalifa M, Rezgui A, Alaoua A, Ben Jazia E, Braham A, et al. La maladie de
Takayasu dans la région centre de la Tunisie. À propos de 27 cas. J Mal Vasc. 2010 Feb 1;35(1):4–11.
14. Hahn D, Thomson PD, Kala U, Beale PG, Levin SE. A review of Takayasu’s arteritis in children in
Gauteng, South Africa. Pediatr Nephrol [Internet]. 1998 Oct [cited 2022 Sep 16];12(8):668–75. Available
from: https://pubmed.ncbi.nlm.nih.gov/9811393/
15. Mwipatayi BP, Jeffery PC, Beningfield SJ, Matley PJ, Naidoo NG, Kalla AA, et al. Takayasu arteritis:
clinical features and management: report of 272 cases. ANZ J Surg [Internet]. 2005 Mar 1 [cited 2022 Sep
16];75(3):110–7. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1445-2197.2005.03312.x
5
Posted on 29 Nov 2022 — The copyright holder is the author/funder. All rights reserved. No reuse without permission. — https://doi.org/10.22541/au.166971977.73825050/v1 — This a preprint and has not been peer reviewed. Data may be preliminary.
16. Pallangyo P, Epafra E, Nicholaus P, Lyimo F, Kazahura P, Janabi M. Bilateral ocular ischemia-induced blindness as a presenting manifestation of Takayasu arteritis: A case report. J Med Case Rep [Internet]. 2017 Jun 10 [cited 2022 Sep 16];11(1):1–5. Available from:
https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-017-1330-3
17. Pallangyo P, Misidai N, Hemed NR, Swai HJ, Mkojera Z, Bhalia S, et al. Takayasu Arteritis Mistaken
for Epilepsy: A Case Presenting With Convulsive Syncope. J Med Cases [Internet]. 2020 [cited 2022 Sep
16];11(2):37. Available from: /pmc/articles/PMC8383632/
18. Kalungi S, Kigonya E, Eyoku S, Atwine D, Kavuma J, Sebatta E, et al. Takayasu’s arteritis (pulseless disease) in Uganda. Afr Health Sci [Internet]. 2004 [cited 2022 Sep 16];4(3):185. Available from:
/pmc/articles/PMC2688324/
19. Fielder JF. Case 4 — A 23-Year-Old Woman Admitted to Kijabe Mission Hospital With Bilateral
Lower Extremity Gangrene. Medscape Gen Med [Internet]. 2004 [cited 2022 Sep 16];6(1):56. Available from:
/pmc/articles/PMC1140744/
20. Barasa L, Salyani A, Bika J, Otieno F, Sokhi D. Takayasu arteritis: A rare cause of chronic headache. Clin
Case Reports [Internet]. 2021 Sep 1 [cited 2022 Jul 20];9(9). Available from: /pmc/articles/PMC8455962/
21. Hellmich B, Agueda A, Monti S, Buttgereit F, De Boysson H, Brouwer E, et al. 2018 Update of the
EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis [Internet]. 2020
Jan 1 [cited 2022 Sep 16];79(1):19–130. Available from: https://ard.bmj.com/content/79/1/19
22. Maz M, Chung SA, Abril A, Langford CA, Gorelik M, Guyatt G, et al. 2021 American College of
Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu
Arteritis. Arthritis Care Res [Internet]. 2021 [cited 2022 Sep 16];73(8):1071–87. Available from: https://www.
23. Lee GY, Jang SY, Ko SM, Kim EK, Lee SH, Han H, et al. Cardiovascular manifestations of Takayasu
arteritis and their relationship to the disease activity: Analysis of 204 Korean patients at a single center. Int
J Cardiol. 2012 Aug 9;159(1):14–20.
24. Soto ME, Espinola N, Flores-Suarez LF, Reyes PA. Takayasu arteritis: clinical features in 110
Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol [Internet]. 2008 May 1 [cited 2022 Nov 22];26(3 Suppl 49):S9-15. Available from: https://europepmc.org/article/med/18799047
25. Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu’s disease. Clinical and statistical analyses of related prognostic factors. Circulation [Internet]. 1994 [cited 2022 Nov
22];90(4):1855–60. Available from: https://pubmed.ncbi.nlm.nih.gov/7923672/
26. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med [Internet]. 1994 Jun 1 [cited 2022 Nov 22];120(11):919–29. Available from: https://pubmed.ncbi.nlm.nih.gov/7909656/
27. Comarmond C, Biard L, Lambert M, Mekinian A, Ferfar Y, Kahn JE, et al. Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318
Patients. Circulation [Internet]. 2017 Sep 1 [cited 2022 Nov 22];136(12):1114–22. Available from: https://pubmed.ncbi.nlm.nih.gov/28701469/
28. Watanabe Y, Miyata T, Tanemoto K. Current Clinical Features of New Patients With Takayasu Arteritis
Observed From Cross-Country Research in Japan: Age and Sex Specificity. Circulation [Internet]. 2015 Nov
3 [cited 2022 Nov 22];132(18):1701–9. Available from: https://pubmed.ncbi.nlm.nih.gov/26354799/
29. Misra DP, Rathore U, Patro P, Agarwal V, Sharma A. Patient-Reported Outcome Measures in Takayasu
Arteritis: A Systematic Review and Meta-Analysis. Rheumatol Ther [Internet]. 2021 Sep 1 [cited 2022 Nov
22];8(3):1073–93. Available from: https://pubmed.ncbi.nlm.nih.gov/34398434/
6
Posted on 29 Nov 2022 — The copyright holder is the author/funder. All rights reserved. No reuse without permission. — https://doi.org/10.22541/au.166971977.73825050/v1 — This a preprint and has not been peer reviewed. Data may be preliminary.
Hosted file
Image file.docx available at https://authorea.com/users/557702/articles/607253-ischemicstroke-at-first-presentation-of-takayasu-arteritis-in-a-young-african-male-from-kenyaeast-africa-case-report-and-brief-literature-review
7